Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

trial transparency

This page shows the latest trial transparency news and features for those working in and with pharma, biotech and healthcare.

EMA to support real-world monitoring of COVID-19 treatments/vaccines

EMA to support real-world monitoring of COVID-19 treatments/vaccines

The agency called for transparency surrounding trial protocols and results, and collaboration between researchers to ensure high-quality studies.

Latest news

  • UCB launches online clinical trial tool UCB launches online clinical trial tool

    Although UCB signed up to a clinical trial data sharing portal in 2014 it only received a mid-table ranking from an AllTrials audit last year. ... Industry-wide pressure from the campaigning group is set to be increased following the drive to name trial

  • AllTrials tracker site names clinical trial non-reporters AllTrials tracker site names clinical trial non-reporters

    fine trial sponsors up to $10, 000 per day who fail to publish results “there are, though, trials on that register whose results are years overdue, and to date you have

  • Shire says all its studies will publish in open access journals Shire says all its studies will publish in open access journals

    The new policy comes against a backdrop of a lot of promises by the pharma industry to improve on transparency that have often fallen short. ... Last year for example, an audit of 42 top manufacturers from the EU, US and Japan by the trial transparency

  • The state of trust The state of trust

    The campaign group has been at the forefront of efforts to increase clinical trial transparency - through open publication - and a year ago revealed that around half of all trials run by ... We have been in conversation with AllTrials to make sure that

  • Audit exposes gaps in pharma's promises on trial transparency Audit exposes gaps in pharma's promises on trial transparency

    study. An audit of 42 top manufacturers from the EU, US and Japan by the trial transparency pressure group AllTrials reveals that GlaxoSmithKline sits at the top of the tree for ... transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo

More from news
Approximately 3 fully matching, plus 74 partially matching documents found.

Latest Intelligence

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    LEO’s VP for Europe North Geraldine Murphy (pictured above) sat down with PME to talk about trial transparency and why opening up is so important. ... Every company has their own policies regarding trial transparency, but we need to begin to learn to

  • Interview: Beate Wieseler, IQWIG Interview: Beate Wieseler, IQWIG

    That is still open.”. IQWiG and clinical trial transparency. In addition to its role in German drug pricing, IQWiG has also emerged as one of the leading organisations in the campaign ... for greater transparency of clinical trial detail, becoming one

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    Issue of transparency. It's a similar story when it comes to pharma's hot topic of the past 12 months – transparency of clinical trial data. ... on transparency as part of his role on EFPIA's research directors group.

  • Clinical trial regulation in Mexico Clinical trial regulation in Mexico

    private hospital and trial centres can be found concentrated in large urban areas. ... Moreover, training for clinical trial personnel, eg managers and coordinators, is also improving.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Sanofi CEO Viehbacher to head EFPIA Sanofi CEO Viehbacher to head EFPIA

    One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • How to measure and maximise your patient recruitment spend ROI How to measure and maximise your patient recruitment spend ROI

    Using emotion to connect with people through your clinical trial advertising is important. ... Customised, adaptable digital marketing campaigns, better sharing and transparency of data, health seeker-centric trial design, and remote patient monitoring

  • New ICMJE Guidelines and their Impact on Biotech

    Failure to do so will prevent the reporting of trial results in an ICMJE member journal, and probably many other journals that adhere to ICMJE guidelines. ... While the goal of ICMJE of increasing transparency in the reporting of clinical trial data is

  • Clinical data Transparency

    As the date for legislation approaches, each week brings more debate regarding the issue of clinical data transparency. ... Within the industry there appears to an appetite for increased transparency, with recognition of the scientific and patient

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...

Quick links